DiviDrip · CRNX

CRNX — Crinetics Pharmaceuticals, Inc.

CRNX is Crinetics Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $84.95. Market cap: $9.01B. Capital Quality Rank: 71/100 — Efficient operator.

Stock snapshot

Price$84.95
Market cap$9.01B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)71 / 100 · Efficient operator
ROIC (TTM)-45.8%
Revenue CAGR (3y)17.6%
Shareholder buyback yield-14.11%
Altman Z-score zoneSafe

About CRNX

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Listed2018Employees594HQSan Diego, CASectorHealthcareWebsitecrinetics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside CRNX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is CRNX's current stock price?

CRNX (Crinetics Pharmaceuticals, Inc.) is currently trading at $84.95.

Does CRNX pay a dividend?

CRNX (Crinetics Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is CRNX's Capital Quality Rank?

CRNX has a Capital Quality Rank of 71/100 — Efficient operator. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track CRNX in DiviDrip

Add CRNX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow